Quantum Genomics Announces Interim Analysis from Study of Firibastat in Renal Failure Patients
PARIS and NEW YORK, May 06, 2020 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in developing a new drug class that directly targets the brain to treat difficult-to-treat and …